What is the place in therapy for nirmatrelvir/ritonavir?

BMJ Evid Based Med. 2023 Oct;28(5):287-290. doi: 10.1136/bmjebm-2022-112064. Epub 2022 Nov 16.

Authors

Todd C Lee¹, Jason M Pogue², Erin K McCreary³, Andrew M Morris⁴

Affiliations

¹ Clinical Practice Assessment Unit, Department of Medicine, McGill University Faculty of Medicine, Montreal, Québec, Canada [email protected].
² Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
³ Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
⁴ Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

PMID: 36384743
DOI: 10.1136/bmjebm-2022-112064

No abstract available

Keywords: COVID-19; THERAPEUTICS.

MeSH terms

Humans
Ritonavir* / therapeutic use

Substances

nirmatrelvir
Ritonavir